ArticleBMC gastroenterology2026
Association of postoperative day 1 procalcitonin levels with short-term mortality after liver transplantation: a single-center retrospective cohort study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative complications, especially infections, are important causes of poor prognosis after liver transplantation. Procalcitonin (PCT) has been proven to be a sensitive marker of infection and inflammation in many diseases. As a result, the purpose of this study was to determine the connection between early postoperative PCT levels and mortality in liver transplant patients.
methodsWe included 205 liver transplant recipients who underwent orthotopic allogeneic liver transplantation at Sun Yat-sen University's Sun Yat-sen Memorial Hospital. We grouped the patients according to the tertile of PCT levels on postoperative day one (POD 1) and divided the patients into three groups: Q1 (≤ 2.0 ng/ml), Q2 (2.1-5.0 ng/ml), and Q3 (≥ 5.1 ng/ml). To analyze the curvilinear association between PCT levels and 90-day mortality and in-hospital mortality, we used Spearman's rank correlation coefficient. The Kaplan-Meier method was used to assess survival rates at 30, 60 and 90 days after liver transplantation. The Log-rank test was used to analyze differences in survival rates between different PCT groups.
resultsHigher POD1 PCT levels were associated with increased 90-day and in-hospital mortality. Furthermore, this study revealed a statistically significant decrease in ICU-free days at 28-day, hospital-free days at 28-day, CRRT-free hours at 28-day, and hospital-free days at 60-day among patients in the group of high PCT level.
conclusionsHigher POD1 PCT levels were associated with worse short-term postoperative outcomes after liver transplantation. However, POD1 PCT should be interpreted as a potential early risk-associated biomarker rather than as an established independent prognostic factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.